Free Trial
NYSE:AVTR

Avantor (AVTR) Stock Price, News & Analysis

Avantor logo
$15.79 -0.42 (-2.60%)
Closing price 04/1/2025 03:59 PM Eastern
Extended Trading
$15.80 +0.01 (+0.07%)
As of 08:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Avantor Stock (NYSE:AVTR)

Key Stats

Today's Range
$15.69
$16.29
50-Day Range
$15.50
$22.49
52-Week Range
$15.37
$28.00
Volume
7.47 million shs
Average Volume
6.46 million shs
Market Capitalization
$10.75 billion
P/E Ratio
15.18
Dividend Yield
N/A
Price Target
$25.50
Consensus Rating
Moderate Buy

Company Overview

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Remove Ads

Avantor Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
96th Percentile Overall Score

AVTR MarketRank™: 

Avantor scored higher than 96% of companies evaluated by MarketBeat, and ranked 35th out of 930 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Avantor has received a consensus rating of Moderate Buy. The company's average rating score is 2.77, and is based on 10 buy ratings, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Avantor has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Avantor's stock forecast and price target.
  • Earnings Growth

    Earnings for Avantor are expected to grow by 13.21% in the coming year, from $1.06 to $1.20 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Avantor is 15.18, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 22.58.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Avantor is 15.18, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 23.42.

  • Price to Earnings Growth Ratio

    Avantor has a PEG Ratio of 1.55. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Avantor has a P/B Ratio of 1.80. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Avantor's valuation and earnings.
  • Percentage of Shares Shorted

    4.71% of the float of Avantor has been sold short.
  • Short Interest Ratio / Days to Cover

    Avantor has a short interest ratio ("days to cover") of 5.
  • Change versus previous month

    Short interest in Avantor has recently increased by 11.49%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Avantor does not currently pay a dividend.

  • Dividend Growth

    Avantor does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.71% of the float of Avantor has been sold short.
  • Short Interest Ratio / Days to Cover

    Avantor has a short interest ratio ("days to cover") of 5.
  • Change versus previous month

    Short interest in Avantor has recently increased by 11.49%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Avantor has a news sentiment score of 1.02. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.70 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 25 news articles for Avantor this week, compared to 10 articles on an average week.
  • Search Interest

    Only 3 people have searched for AVTR on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.
  • MarketBeat Follows

    3 people have added Avantor to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Avantor insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $151,897.00 in company stock.

  • Percentage Held by Insiders

    Only 1.50% of the stock of Avantor is held by insiders.

  • Percentage Held by Institutions

    95.08% of the stock of Avantor is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Avantor's insider trading history.
Receive AVTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avantor and its competitors with MarketBeat's FREE daily newsletter.

AVTR Stock News Headlines

Partner with Elon Musk on Project Colossus… Before May 1st
Even though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks like you… To partner with Elon on what he believes will be the biggest AI project of the century… Starting with as little as $500.
Zacks Research Issues Positive Estimate for Avantor Earnings
Zacks Research Comments on Avantor's Q3 Earnings (NYSE:AVTR)
Avantor price target lowered to $24 from $27 at TD Cowen
See More Headlines

AVTR Stock Analysis - Frequently Asked Questions

Avantor's stock was trading at $21.07 at the beginning of 2025. Since then, AVTR shares have decreased by 25.1% and is now trading at $15.7890.
View the best growth stocks for 2025 here
.

Avantor, Inc. (NYSE:AVTR) issued its quarterly earnings data on Wednesday, February, 12th. The company reported $0.27 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.26 by $0.01. Avantor had a net margin of 10.49% and a trailing twelve-month return on equity of 12.17%.

Avantor (AVTR) raised $3 billion in an initial public offering on Friday, May 17th 2019. The company issued 154,000,000 shares at $18.00-$21.00 per share. Goldman Sachs, J.P. Morgan, BofA Merrill Lynch, Barclays and Jefferies served as the underwriters for the IPO and Credit Suisse, Deutsche Bank Securities, Evercore ISI, Guggenheim Securities, Morgan Stanley, UBS Investment Bank, Citigroup, Cowen, Piper Jaffray, RBC Capital Markets, Baird, William Blair, Janney Montgomery Scott, KeyBanc Capital Markets, PJT Partners, Raymond James, Stephens, Stifel, SunTrust Robinson Humphrey, Wells Fargo Securities and Drexel Hamilton were co-managers.

Shares of AVTR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Avantor investors own include American Water Works (AWK), Waste Connections (WCN), The RMR Group (RMR), Humana (HUM), Voyager Therapeutics (VYGR), DiamondRock Hospitality (DRH) and AUO (AUOTY).

Company Calendar

Last Earnings
2/12/2025
Today
4/02/2025
Next Earnings (Estimated)
4/25/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Analytical instruments
Sub-Industry
Measuring And Control Equipment
Current Symbol
NYSE:AVTR
Fax
N/A
Employees
14,500
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$25.50
High Stock Price Target
$31.00
Low Stock Price Target
$18.00
Potential Upside/Downside
+61.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.77
Research Coverage
13 Analysts

Profitability

Trailing P/E Ratio
15.18
Forward P/E Ratio
14.90
P/E Growth
1.55
Net Income
$711.50 million
Pretax Margin
12.59%

Debt

Sales & Book Value

Annual Sales
$6.78 billion
Cash Flow
$1.47 per share
Price / Cash Flow
10.76
Book Value
$8.75 per share
Price / Book
1.80

Miscellaneous

Free Float
672,051,000
Market Cap
$10.75 billion
Optionable
Optionable
Beta
1.30
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NYSE:AVTR) was last updated on 4/2/2025 by MarketBeat.com Staff
From Our Partners